NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $358,000 | +67.3% | 1,612 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $214,000 | -85.4% | 1,612 | -81.0% | 0.00% | -88.9% |
| Q4 2020 | $1,464,000 | +59.3% | 8,462 | +2.6% | 0.02% | +50.0% |
| Q3 2020 | $919,000 | -72.4% | 8,250 | -85.3% | 0.01% | -73.9% |
| Q2 2020 | $3,331,000 | -12.1% | 56,160 | -0.2% | 0.05% | -23.3% |
| Q1 2020 | $3,790,000 | -12.0% | 56,270 | +0.5% | 0.06% | +39.5% |
| Q4 2019 | $4,305,000 | +1.7% | 56,010 | -1.0% | 0.04% | -6.5% |
| Q3 2019 | $4,233,000 | +48.4% | 56,600 | +25.5% | 0.05% | +48.4% |
| Q2 2019 | $2,852,000 | +31.2% | 45,100 | 0.0% | 0.03% | +29.2% |
| Q1 2019 | $2,173,000 | +3004.3% | 45,100 | +2047.6% | 0.02% | +2300.0% |
| Q4 2018 | $70,000 | – | 2,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $24,386,000 | 14.72% |
| HARTLINE INVESTMENT CORP/ | 335,191 | $58,001,000 | 8.32% |
| Deep Track Capital, LP | 1,341,300 | $93,220,000 | 6.13% |
| MORGAN JESS S & CO INC | 48,345 | $3,360,000 | 3.48% |
| Taylor Frigon Capital Management LLC | 68,908 | $4,789,000 | 2.49% |
| HighVista Strategies LLC | 28,007 | $1,946,000 | 1.18% |
| Private Harbour Investment Management & Counsel, LLC | 13,106 | $911,000 | 1.01% |
| Lloyd Park, LLC | 9,325 | $648,000 | 0.68% |
| Baillie Gifford | 9,116,230 | $633,578,000 | 0.65% |
| HAP Trading, LLC | 110,900 | $10,575,000 | 0.53% |